Preventing Lymphedema in Axillary Lymph Node Dissection
Reason given: slow accrual; diminished funding
Key facts
- Where
- Jacksonville and Rochester, United StatesSee the 2 sites
Where in United States
- Mayo Clinic in FloridaJacksonville, United StatesNo longer taking part
- Mayo Clinic in RochesterRochester, United StatesNo longer taking part
Trial details
- Who runs it
- Mayo Clinic
- Trial code
- NCT03428581
- Record updated
- 24 February 2026
- Original description
The researchers are trying to answer if axillary reverse mapping (ARM) with lympho-venous bypass (LVB) in patients undergoing an axillary lymph node dissection reduces the rate and severity of post-operative lymphedema of the arm.Read full original descriptionShow less
Preventing Lymphedema in Patients Undergoing Axillary Lymph Node Dissection Via Axillary Reverse Mapping and Lympho-venous Bypass
The researchers are trying to answer if axillary reverse mapping (ARM) with lympho-venous bypass (LVB) in patients undergoing an axillary lymph node dissection reduces the rate and severity of post-operative lymphedema of the arm.
Inclusion: Patients scheduled to undergo an axillary lymph node dissection; Patients who in the surgeon's judgement are at high risk to convert to an axillary lymph node dissection based intraoperative findings; English speaking.
Exclusion: Prior ipsilateral axillary lymph node dissection; Prior ipsilateral axillary radiation; Previous treatment for lymphedema of either arm or prescribed prophylactic treatment for lymphedema; Patients undergoing sentinel lymph node biopsy only or at low risk of converting to an axillary lymph node dissection in the surgeon's judgement; Pregnant patients cannot participate in the substudy.